Quality of life in patients with metastatic renal cell carcinoma treated with sunitinib or interferon alfa: Results from a phase III randomized trial

David Cella*, Jim Z. Li, Joseph C. Cappelleri, Andrew Bushmakin, Claudie Charbonneau, Sindy T. Kim, Isan Chen, Robert J. Motzer

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

102 Scopus citations

Fingerprint

Dive into the research topics of 'Quality of life in patients with metastatic renal cell carcinoma treated with sunitinib or interferon alfa: Results from a phase III randomized trial'. Together they form a unique fingerprint.

Medicine & Life Sciences